XTX Topco Ltd purchased a new stake in UiPath, Inc. (NYSE:PATH - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 52,922 shares of the company's stock, valued at approximately $545,000.
Other large investors have also added to or reduced their stakes in the company. Federated Hermes Inc. lifted its holdings in UiPath by 479.3% during the first quarter. Federated Hermes Inc. now owns 5,720,096 shares of the company's stock worth $58,917,000 after acquiring an additional 4,732,712 shares during the period. Senvest Management LLC lifted its stake in shares of UiPath by 29.2% in the 4th quarter. Senvest Management LLC now owns 14,074,783 shares of the company's stock valued at $178,890,000 after acquiring an additional 3,180,300 shares during the last quarter. AQR Capital Management LLC lifted its holdings in UiPath by 45.3% in the 4th quarter. AQR Capital Management LLC now owns 6,646,320 shares of the company's stock worth $84,209,000 after buying an additional 2,072,089 shares during the period. Jacobs Levy Equity Management Inc. lifted its holdings in UiPath by 35.6% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 5,459,071 shares of the company's stock worth $69,385,000 after buying an additional 1,432,569 shares during the period. Finally, Marshall Wace LLP lifted its holdings in UiPath by 111.8% in the 4th quarter. Marshall Wace LLP now owns 2,456,102 shares of the company's stock worth $31,217,000 after buying an additional 1,296,382 shares during the period. Institutional investors and hedge funds own 62.50% of the company's stock.
UiPath Price Performance
UiPath stock traded down $0.28 during midday trading on Friday, hitting $10.65. 9,073,690 shares of the stock were exchanged, compared to its average volume of 14,424,310. UiPath, Inc. has a 1 year low of $9.38 and a 1 year high of $15.93. The firm has a market cap of $5.70 billion, a P/E ratio of -88.74, a P/E/G ratio of 13.97 and a beta of 1.03. The company has a 50 day moving average price of $12.45 and a two-hundred day moving average price of $12.30.
UiPath (NYSE:PATH - Get Free Report) last announced its quarterly earnings data on Thursday, May 29th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.01. The company had revenue of $356.62 million during the quarter, compared to analyst estimates of $332.17 million. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. The firm's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period last year, the business earned $0.13 EPS. As a group, analysts predict that UiPath, Inc. will post -0.17 EPS for the current year.
Insider Activity
In other UiPath news, CEO Daniel Dines sold 45,000 shares of the business's stock in a transaction dated Wednesday, July 16th. The shares were sold at an average price of $12.43, for a total transaction of $559,350.00. Following the sale, the chief executive officer directly owned 5,058,376 shares in the company, valued at approximately $62,875,613.68. The trade was a 0.88% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Ashim Gupta sold 56,322 shares of the business's stock in a transaction dated Wednesday, July 2nd. The stock was sold at an average price of $12.72, for a total transaction of $716,415.84. Following the sale, the chief financial officer owned 859,991 shares in the company, valued at $10,939,085.52. This trade represents a 6.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 831,310 shares of company stock valued at $10,428,922 over the last ninety days. Company insiders own 23.19% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on the company. Wall Street Zen cut UiPath from a "strong-buy" rating to a "buy" rating in a research note on Sunday, August 3rd. Needham & Company LLC reiterated a "hold" rating on shares of UiPath in a research report on Friday, May 30th. BMO Capital Markets boosted their price objective on UiPath from $11.50 to $15.50 and gave the stock a "market perform" rating in a research note on Friday, May 30th. Truist Financial upped their target price on UiPath from $12.00 to $13.00 and gave the company a "hold" rating in a research note on Friday, May 30th. Finally, Morgan Stanley upped their target price on UiPath from $12.00 to $15.00 and gave the company an "equal weight" rating in a research report on Monday, June 2nd. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $13.83.
View Our Latest Research Report on UiPath
UiPath Company Profile
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Articles

Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report